DRUG-INDUCED HEPATITIS AND SOME MEDICAL APPROACHES
The paper evaluates the efficacy of Silimar in the treatment of patients with drug-induced hepatitis concurrent with cholestastic syndrome, who have received chemotherapy for cancer.